Compare RCUS & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | CSTM |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2018 | 2013 |
| Metric | RCUS | CSTM |
|---|---|---|
| Price | $20.03 | $23.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $28.89 | $23.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 02-24-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | $240,000,000.00 | ★ $7,969,000,000.00 |
| Revenue This Year | N/A | $9.76 |
| Revenue Next Year | N/A | $8.10 |
| P/E Ratio | ★ N/A | $29.61 |
| Revenue Growth | N/A | ★ 11.22 |
| 52 Week Low | $6.50 | $7.33 |
| 52 Week High | $26.40 | $25.15 |
| Indicator | RCUS | CSTM |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 60.45 |
| Support Level | $20.79 | $21.95 |
| Resistance Level | $22.29 | $25.15 |
| Average True Range (ATR) | 1.13 | 0.95 |
| MACD | -0.20 | -0.03 |
| Stochastic Oscillator | 0.45 | 47.18 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.